| 101 |
|
Controlled activity polymers. IX copolymers of acrylic acid and isomericN-alkylacrylamide monomers with pendent �naphthol ester moieties: Hydrolytic release studies
|
Boudreaux, C. J
|
Elsevier Science Publishers
|
1980
|
|
|
|
| 102 |
|
Controlled activity polymers. VIII. Copolymers of acrylic acid and isomeric N-akylacrylamide with pendent �naphthol esters moieties: Synthesis and characterization
|
Boudreaux, C. J
|
Elsevier Science Publishers
|
1980
|
|
|
|
| 103 |
|
Controlled activity polymers. XI Hydrolytic release studies of hydrophilic copolymers with labile esters of model allelopathic phenols
|
Boudreaux, C. J
|
Elsevier Science Publishers
|
1980
|
|
|
|
| 104 |
|
Controlled activity polymers. X synthetically tailored monomers and copolymers with hydrolytically-labile pendent esters of allelopathic phenols
|
Boudreaux, C. J
|
Elsevier Science Publishers
|
1980
|
|
|
|
| 105 |
|
Controlled delivery of antibodies against leukocyte adhesion molecules from polymer matrices
|
Parkhurst, M. R
|
Elsevier Science Publishers
|
1980
|
|
|
|
| 106 |
|
Controlled drug release from coated floating ion exchange resin beads
|
Atyabi, F
|
Elsevier Science Publishers
|
1980
|
|
|
|
| 107 |
|
Controlled macromolecule release from poly(phosphazene) matrices
|
Ibim, S. M
|
Elsevier Science Publishers
|
1980
|
|
|
|
| 108 |
|
Controlled release of diuron from granules based on a lignin matrix system
|
Cotterill, J. V
|
Elsevier Science Publishers
|
1980
|
|
|
|
| 109 |
|
Controlled release of fragrances from polymers I. Thermodynamic analysis
|
Peppas, N. A
|
Elsevier Science Publishers
|
1980
|
|
|
|
| 110 |
|
Controlled release of human growth hormone in rats following parenteral administration of poloxamer gels
|
Katakam, M
|
Elsevier Science Publishers
|
1980
|
|
|
|
| 111 |
|
Controlled release of injectable zinc/recombinant hirudin co-precipitates: development and validation of release model
|
Gietz, U
|
Elsevier Science Publishers
|
1980
|
|
|
|
| 112 |
|
Controlled release of interleukin-2 for tumour immunotherapy using alginate/chitosan porous microspheres
|
Liu, L.-S
|
Elsevier Science Publishers
|
1980
|
|
|
|
| 113 |
|
Controlled release of ionic compounds from poly (L-lactide) microspheresproduced by precipitation with a compressed antisolvent
|
Falk, R
|
Elsevier Science Publishers
|
1980
|
|
|
|
| 114 |
|
Controlled release of plasmid DNA
|
Jong, Y. S
|
Elsevier Science Publishers
|
1980
|
|
|
|
| 115 |
|
Controlled release of proteins from dextran hydrogels
|
Hennink, W. E
|
Elsevier Science Publishers
|
1980
|
|
|
|
| 116 |
|
Controlled release of steroids from lactide/curly epsilon-caprolactone copolymers
|
Bero, M
|
Elsevier Science Publishers
|
1980
|
|
|
|
| 117 |
|
Controlled release of tobramycin sulfate from poly(ortho esters) implantable discs for the treatment of osteomyelitis
|
Du, J
|
Elsevier Science Publishers
|
1980
|
|
|
|
| 118 |
|
Controlled release of U-86983 from double-layer biodegradable matrices: effect of additives on release mechanism and kinetics
|
Song, C. X
|
Elsevier Science Publishers
|
1980
|
|
|
|
| 119 |
|
Control of molecular polymorphisms by a structured carbohydrate/ceramic delivery vehicle - aquasomes
|
Kossovsky, N
|
Elsevier Science Publishers
|
1980
|
|
|
|
| 120 |
|
Co-polymerised peptide particles (CPP) I: synthesis, characterisation and in vitro studies on a novel oral nanoparticulate delivery system
|
Hillery, A. M
|
Elsevier Science Publishers
|
1980
|
|
|
|
Boudreaux, C. J
(4)
